Kuling Biology
Latest round
- Angel
Last raised
- May 2017
Total raised
- Undisclosed
Investors
- 1
About Kuling Biology
Established in 2014, and based in Beijng, China, Kuling Biology is a small molecule drug company that screens and identifies small-molecule drug and develops clinics. Kuling Biology focuses on immune-related small-molecule drug screening, identification, and clinical development. The company generates revenue by developing small-molecule drug screening identification and clinics.
Who invested in Kuling Biology
1 investor across 1 round
See all investors in Kuling Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
May 24, 2017
Amount
Undisclosed
Investors
Questions about Kuling Biology
Who invested in Kuling Biology?
Kuling Biology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kuling Biology raised?
Kuling Biology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kuling Biology last raise money?
Kuling Biology's most recent round on record is a Angel, in May 2017.
What does Kuling Biology do?
Established in 2014, and based in Beijng, China, Kuling Biology is a small molecule drug company that screens and identifies small-molecule drug and develops clinics.
Where is Kuling Biology headquartered?
Kuling Biology is headquartered in Beijing, China.
Which VCs invest in companies like Kuling Biology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Kuling Biology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Kuling Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.